Bisphosphonate (BP) Treatment and Renal Impairment (RI) in Women with Postmenopausal Osteoporosis (PMO) in UK

被引：0
|
作者：
Xue, Fei [1 ]
Wentworth, Charles [2 ]
Petraro, Paul [1 ]
机构：
[1] Amgen Inc, CfOR, Thousand Oaks, CA 91320 USA
[2] Analyt Consulting Solut Inc, Wakefield, RI USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
514
引用
收藏
页码：271 / 272
页数：2
相关论文
共 50 条
  • [31] Romosozumab Treatment in Postmenopausal Women with Osteoporosis
    Cosman, F.
    Crittenden, D. B.
    Adachi, J. D.
    Binkley, N.
    Czerwinski, E.
    Ferrari, S.
    Hofbauer, L. C.
    Lau, E.
    Lewiecki, E. M.
    Miyauchi, A.
    Zerbini, C. A. F.
    Milmont, C. E.
    Chen, L.
    Maddox, J.
    Meisner, P. D.
    Libanati, C.
    Grauer, A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (16): : 1532 - 1543
  • [32] Optimising bisphosphonate treatment outcomes in postmenopausal osteoporosis: review and Italian experience
    Rossini, M.
    Di Munno, O.
    Gatti, D.
    Giannini, S.
    Minisola, S.
    Varenna, M.
    Adami, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (04) : 728 - 735
  • [33] Adherence to bisphosphonates (BPs) is associated with reduced fracture risk in women with postmenopausal osteoporosis (PMO)
    Siris, E
    Harris, S
    Silverman, S
    Abbott, T
    Barr, C
    Rosen, C
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (06): : 807 - 807
  • [34] METHODOLOGY OF AN OBSERVATIONAL STUDY TO EVALUATE THE CARE MAP OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO) IN SWITZERLAND
    Lippuner, K.
    Pendl, G.
    Biteeva, I
    Murigande, C.
    Schwenkglenks, M.
    VALUE IN HEALTH, 2013, 16 (07) : A574 - A574
  • [35] The effect of previous treatment with bisphosphonate and renal impairment on the response to denosumab in osteoporosis: a 'real-life' study
    Fraser, T. R.
    Flogaitis, I.
    Moore, A. E.
    Hampson, G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2020, 43 (04) : 469 - 475
  • [36] The effect of previous treatment with bisphosphonate and renal impairment on the response to denosumab in osteoporosis: a ‘real-life’ study
    T. R. Fraser
    I. Flogaitis
    A. E. Moore
    G. Hampson
    Journal of Endocrinological Investigation, 2020, 43 : 469 - 475
  • [37] Comparison of teriparatide and bisphosphonate in the treatment of postmenopausal osteoporosis: A meta-analysis
    Li, Yudong
    Li, Wenchang
    Lee, Katrin
    ASIAN JOURNAL OF SURGERY, 2025, 48 (01) : 454 - 456
  • [38] Prolonged-efficacy of bisphosphonate in postmenopausal women with osteoporosis and chronic liver disease
    Arase, Yasuji
    Suzuki, Fumitaka
    Suzuki, Yoshiyuki
    Akuta, Norio
    Kobayashi, Masahiro
    Kawamura, Yusuke
    Yatsuji, Hiromi
    Sezaki, Hitomi
    Hosaka, Tetsuya
    Ikeda, Kenji
    Kumada, Hiromitsu
    JOURNAL OF MEDICAL VIROLOGY, 2008, 80 (07) : 1302 - 1307
  • [39] Hip structure analysis of bisphosphonate-treated Japanese postmenopausal women with osteoporosis
    Junichi Takada
    Genichiro Katahira
    Kousuke Iba
    Takashi Yoshizaki
    Toshihiko Yamashita
    Journal of Bone and Mineral Metabolism, 2011, 29 : 458 - 465
  • [40] Hip structure analysis of bisphosphonate-treated Japanese postmenopausal women with osteoporosis
    Takada, Junichi
    Katahira, Genichiro
    Iba, Kousuke
    Yoshizaki, Takashi
    Yamashita, Toshihiko
    JOURNAL OF BONE AND MINERAL METABOLISM, 2011, 29 (04) : 458 - 465
12345